12-week Exercise Intervention Program Versus Observation in Early Stage Breast Cancer Patients on the Impact on Mental Health, Quality of Life and Immune Markers
A Randomized Controlled Study of a 12-week Exercise Intervention Program Versus Observation in Early Stage Breast Cancer Patients on the Impact on Mental Health, Quality of Life and Immune Markers
1 other identifier
interventional
304
1 country
3
Brief Summary
Exercise in early breast cancer patients has the potential to improve depression, anxiety, fatigue, quality of life and even survival. The effects of exercise may come about by way of changes in weight, immune markers and telomere length, but data on this so far has not been conclusive. To better understand the physical, psychological, and biological effects of exercise on breast cancer survivorship, the investigators propose to perform a phase III randomized controlled trial of a 12-week exercise intervention program versus usual care in early stage breast cancer patients, and will follow up the patients prospectively for 5 years, with serial assessment of physical and functional activity, QoL, depression and anxiety scores, telomere length and plasma immune markers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3 breast-cancer
Started Mar 2015
Longer than P75 for phase_3 breast-cancer
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 12, 2015
CompletedFirst Submitted
Initial submission to the registry
March 27, 2018
CompletedFirst Posted
Study publicly available on registry
May 8, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2025
CompletedMay 14, 2018
February 1, 2018
6.8 years
March 27, 2018
May 8, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Improved mental health
Based on the HADS (Hospital Anxiety and Depression Scale) questionnaire, we define a score of ≥8/21 as caseness for anxiety or depression
12 months
Secondary Outcomes (1)
Adherence rate
16 weeks
Study Arms (2)
Exercise intervention
EXPERIMENTALPatients who are randomised to this arm will be enrolled to the exercise programme.
Non-exercise
NO INTERVENTIONPatients who are randomised to the non-exercise group can continue their daily and physical activities as they normally would.
Interventions
Week 1: Patients will undergo an introductory session where the occupational therapist will assess the general condition and physical fitness of the subjects. Week 1 to Week 12: Group exercise sessions supervised by a physiotherapist, twice per week, each session lasting 1 hour, with no more than 8 participants in each group exercise session. The exercise regimen for each session will be personally tailored for the subjects, and will include stretching, cardiovascular and strength training, and cooling down exercises. Week 12 onwards: Patients will receive phone calls- monthly for the first 6 months and then 3 monthly up to the 2-year mark, to encourage them to continue with their exercise regimen at home.
Eligibility Criteria
You may qualify if:
- Female
- Age 21-70 years
- Histological or cytological diagnosis of breast carcinoma
- Stage I-III breast cancer
- Has undergone curative breast cancer surgery with no clinically measurable tumor
- Between 4-12 weeks from the last adjuvant radiotherapy or chemotherapy session, if given, whichever is later. Patients who do not receive adjuvant chemotherapy or radiotherapy can be enrolled and will be randomized within 4-12 weeks of breast cancer surgery.
- Able to sign informed consent
- Able to adhere to study procedures
You may not qualify if:
- Cardiovascular, respiratory, or musculoskeletal problems that preclude moderate physical activity
- Major medical problems deemed by the investigator to be unsuitable for enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
National University Hospital, Singapore
Singapore, 119228, Singapore
Tan Tock Seng Hospital
Singapore, 308433, Singapore
Ng Teng Fong General Hospital
Singapore, 609606, Singapore
Related Publications (2)
Carayol M, Bernard P, Boiche J, Riou F, Mercier B, Cousson-Gelie F, Romain AJ, Delpierre C, Ninot G. Psychological effect of exercise in women with breast cancer receiving adjuvant therapy: what is the optimal dose needed? Ann Oncol. 2013 Feb;24(2):291-300. doi: 10.1093/annonc/mds342. Epub 2012 Oct 5.
PMID: 23041586BACKGROUNDKolden GG, Strauman TJ, Ward A, Kuta J, Woods TE, Schneider KL, Heerey E, Sanborn L, Burt C, Millbrandt L, Kalin NH, Stewart JA, Mullen B. A pilot study of group exercise training (GET) for women with primary breast cancer: feasibility and health benefits. Psychooncology. 2002 Sep-Oct;11(5):447-56. doi: 10.1002/pon.591.
PMID: 12228878BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 27, 2018
First Posted
May 8, 2018
Study Start
March 12, 2015
Primary Completion
December 20, 2021
Study Completion
December 20, 2025
Last Updated
May 14, 2018
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will not share